Nilsine Partners LLC Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nilsine Partners LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,889 shares of the medical equipment provider’s stock after buying an additional 595 shares during the period. Nilsine Partners LLC’s holdings in Intuitive Surgical were worth $3,596,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday. CICC Research started coverage on Intuitive Surgical in a research note on Monday. They issued a “neutral” rating and a $550.00 target price for the company. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Finally, BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,265 shares of company stock worth $21,964,281. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 1.8 %

NASDAQ ISRG opened at $573.48 on Tuesday. The firm has a market cap of $204.26 billion, a PE ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a 50-day moving average of $547.16 and a 200-day moving average of $505.21.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.